JP2024513690A5 - - Google Patents

Info

Publication number
JP2024513690A5
JP2024513690A5 JP2023555752A JP2023555752A JP2024513690A5 JP 2024513690 A5 JP2024513690 A5 JP 2024513690A5 JP 2023555752 A JP2023555752 A JP 2023555752A JP 2023555752 A JP2023555752 A JP 2023555752A JP 2024513690 A5 JP2024513690 A5 JP 2024513690A5
Authority
JP
Japan
Prior art keywords
active substance
mammal
infestation
fleas
ticks
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023555752A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024513690A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/019913 external-priority patent/WO2022192648A1/en
Publication of JP2024513690A publication Critical patent/JP2024513690A/ja
Publication of JP2024513690A5 publication Critical patent/JP2024513690A5/ja
Pending legal-status Critical Current

Links

JP2023555752A 2021-03-11 2022-03-11 哺乳動物におけるノミおよびダニの侵入を制御する方法 Pending JP2024513690A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163159801P 2021-03-11 2021-03-11
US63/159,801 2021-03-11
PCT/US2022/019913 WO2022192648A1 (en) 2021-03-11 2022-03-11 Methods for controlling flea and tick infestations in a mammal

Publications (2)

Publication Number Publication Date
JP2024513690A JP2024513690A (ja) 2024-03-27
JP2024513690A5 true JP2024513690A5 (https=) 2025-03-06

Family

ID=83227137

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023555752A Pending JP2024513690A (ja) 2021-03-11 2022-03-11 哺乳動物におけるノミおよびダニの侵入を制御する方法

Country Status (10)

Country Link
US (1) US20230413819A1 (https=)
EP (1) EP4304722A4 (https=)
JP (1) JP2024513690A (https=)
KR (1) KR20230161996A (https=)
CN (1) CN117500498A (https=)
AU (1) AU2022234415A1 (https=)
BR (1) BR112023017666A2 (https=)
CA (1) CA3211582A1 (https=)
MX (1) MX2023010380A (https=)
WO (1) WO2022192648A1 (https=)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122011100022I1 (de) * 1999-08-12 2011-10-20 Lilly Co Eli Verwendung von Spinosad oder einer Zusammensetzungenthaltend spinosad.
DE602004017347D1 (de) * 2003-11-04 2008-12-04 Intervet Int Bv Azol-pestiziden
UA108200C2 (uk) * 2009-05-08 2015-04-10 Лікарські форми та способи застосування ектопаразитоцидів
CA2764526A1 (en) * 2009-06-24 2010-12-29 Christine Kritikou The use of spinosyns and spinosyn compositions against diseases caused by protozoans, viral infections and cancer
WO2012155352A1 (en) * 2011-05-19 2012-11-22 Eli Lilly And Company Dihydroisoxazole compounds, parasiticidal uses and formulations thereof
WO2020201440A1 (en) * 2019-04-03 2020-10-08 Virbac Low dose fluralaner compositions for protection against parasitic invertebrate pest

Similar Documents

Publication Publication Date Title
JP6530753B2 (ja) イソオキサゾリン化合物の抗寄生生物薬使用
JP2022554276A5 (https=)
FI3952880T3 (fi) 2-(2,6-dioksopiperidin-3-yyli)-4-((2-fluori-4-((3-morfolinoatsetidin-1-yyli)metyyli)bentsyyli)amino)isoindoliini-1,3-dioni käytettäväksi non-hodgkinin lymfooman hoidossa
JP2014533735A (ja) 外寄生生物を防除するためのアリール誘導体の使用
DE69725860T2 (de) PLAN ZUR VERABREICHUNG VON H+, K+-ATPase INHIBITOREN
JP2019517587A5 (https=)
FI3007695T3 (fi) Koostumuksia ja menetelmiä anemian hoitamiseksi
JPWO2023054732A5 (https=)
JP2024507810A5 (https=)
JP2021525757A5 (https=)
JP2024513690A5 (https=)
JP2022191405A5 (https=)
EP1689382A1 (de) Pharmazeutische zusammensetzung aus einem beta-3-adrenozeptor-agonisten und einem in den prostaglandinstoffwechsel eingreifendem wirkstoff
JP2013536837A5 (https=)
RU2016137926A (ru) Композиции грапипранта и способы их применения
JP2022511126A5 (https=)
WO2019101971A1 (en) Composition for treating parasites infestations
JP2024511953A5 (https=)
JP2024524996A5 (https=)
JP2021091608A5 (https=)
JP2024511956A5 (https=)
WO2000024388A2 (de) Kombinationsmittel zur behandlung entzünglicher darmerkrankungen von 5-aminosalicylsäure und einem von budenosid, 6-methylprednisolon oder prednisolon
JP2024524933A5 (https=)
IL276437B2 (en) Use of 5-fluoro-4-(4-fluoro-2-methoxyphenyl)-n-{4-[(s-methylsulfonimidoyl)methyl]pyridin-2-yl}pyridin-2-amine for treating diffuse large b-cell lymphoma
EP0472033A2 (de) 3,5-Diiod-L-Thyronin zur TSH-Suppression und Behandlung von Struma